Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer

Fig. 3

Post-treatment STMN1 expression in the pCR and non-pCR groups in ITT population (A); T0-1 and T2-3 groups (B); N0 and N1-3 groups (C); high pathological grade and low pathological grade groups(D); and Ki67 high and low groups (E). The Kaplan–Meier curves for PFS (F) and OS (G) of patients in post-treatment STMN1 high-medium and low groups. Data are presented as means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 by Mann-Whitney U-test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us